Explore
Validate
Learn10281-1-AP
antibody from Proteintech Group
Targeting: LGALS3BP
90K, BTBD17B, CyCAP, gp90, M2BP, MAC-2-BP, TANGO10B
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [14]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10281-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10281-1-AP, RRID:AB_2137066
- Product name
- LGALS3BP antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated LGALS3BP antibody (Cat. #10281-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, IP, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references MZT2A promotes NSCLC viability and invasion by increasing Akt phosphorylation via the MOZART2 domain.
Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2.
Increased LGALS3BP promotes proliferation and migration of oral squamous cell carcinoma via PI3K/AKT pathway.
Increased Mac-2 binding protein glycan isomer in patients at risk for late nonrelapse mortality after HSCT.
Inducible LGALS3BP/90K activates antiviral innate immune responses by targeting TRAF6 and TRAF3 complex.
Marked elevation of serum M2BP-adiponectin complex in men with coronary artery disease.
Shoc2-tranduced ERK1/2 motility signals--Novel insights from functional genomics.
Composition and characteristics of distinct macrophage subpopulations in the mouse thymus.
A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma.
O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.
Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements.
Galectin 3-binding protein is a potential contaminant of recombinantly produced factor IX.
Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles.
Wang H, Jiang X, Cheng Y, Ren H, Hu Y, Zhang Y, Su H, Zou Z, Wang Q, Liu Z, Zhang J, Qiu X
Cancer science 2021 Jun;112(6):2210-2222
Cancer science 2021 Jun;112(6):2210-2222
Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2.
Wang C, Li Y, Yan S, Wang H, Shao X, Xiao M, Yang B, Qin G, Kong R, Chen R, Zhang N
Nature communications 2020 Jun 22;11(1):3162
Nature communications 2020 Jun 22;11(1):3162
Increased LGALS3BP promotes proliferation and migration of oral squamous cell carcinoma via PI3K/AKT pathway.
Zhang X, Ding H, Lu Z, Ding L, Song Y, Jing Y, Hu Q, Dong Y, Ni Y
Cellular signalling 2019 Nov;63:109359
Cellular signalling 2019 Nov;63:109359
Increased Mac-2 binding protein glycan isomer in patients at risk for late nonrelapse mortality after HSCT.
Akahoshi Y, Nakasone H, Kawamura K, Kusuda M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Gomyo A, Tanihara A, Tamaki M, Kimura SI, Kako S, Kanda Y
Blood advances 2019 Nov 12;3(21):3287-3296
Blood advances 2019 Nov 12;3(21):3287-3296
Inducible LGALS3BP/90K activates antiviral innate immune responses by targeting TRAF6 and TRAF3 complex.
Xu G, Xia Z, Deng F, Liu L, Wang Q, Yu Y, Wang F, Zhu C, Liu W, Cheng Z, Zhu Y, Zhou L, Zhang Y, Lu M, Liu S
PLoS pathogens 2019 Aug;15(8):e1008002
PLoS pathogens 2019 Aug;15(8):e1008002
Marked elevation of serum M2BP-adiponectin complex in men with coronary artery disease.
Niinaga R, Yamamoto H, Yoshii M, Uekita H, Yamane N, Kochi I, Matsumoto A, Matsuoka T, Kihara S
Atherosclerosis 2016 Oct;253:70-74
Atherosclerosis 2016 Oct;253:70-74
Shoc2-tranduced ERK1/2 motility signals--Novel insights from functional genomics.
Jeoung M, Jang ER, Liu J, Wang C, Rouchka EC, Li X, Galperin E
Cellular signalling 2016 May;28(5):448-459
Cellular signalling 2016 May;28(5):448-459
Composition and characteristics of distinct macrophage subpopulations in the mouse thymus.
Liu LT, Lang ZF, Li Y, Zhu YJ, Zhang JT, Guo SF, Wang JX, Wang HW, Xu YD
Molecular medicine reports 2013 Jun;7(6):1850-4
Molecular medicine reports 2013 Jun;7(6):1850-4
A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma.
Silverman AM, Nakata R, Shimada H, Sposto R, DeClerck YA
Cancer research 2012 May 1;72(9):2228-38
Cancer research 2012 May 1;72(9):2228-38
O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
Isono T
PloS one 2011 Apr 19;6(4):e18959
PloS one 2011 Apr 19;6(4):e18959
SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.
Kashyap MK, Harsha HC, Renuse S, Pawar H, Sahasrabuddhe NA, Kim MS, Marimuthu A, Keerthikumar S, Muthusamy B, Kandasamy K, Subbannayya Y, Prasad TS, Mahmood R, Chaerkady R, Meltzer SJ, Kumar RV, Rustgi AK, Pandey A
Cancer biology & therapy 2010 Oct 15;10(8):796-810
Cancer biology & therapy 2010 Oct 15;10(8):796-810
Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements.
Gorla L, Mondellini P, Cuccuru G, Miccichè F, Cassinelli G, Cremona M, Pierotti MA, Lanzi C, Bongarzone I
Molecular carcinogenesis 2009 Mar;48(3):220-231
Molecular carcinogenesis 2009 Mar;48(3):220-231
Galectin 3-binding protein is a potential contaminant of recombinantly produced factor IX.
Blostein M, Cuerquis J, Galipeau J
Haemophilia : the official journal of the World Federation of Hemophilia 2007 Nov;13(6):701-6
Haemophilia : the official journal of the World Federation of Hemophilia 2007 Nov;13(6):701-6
Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles.
Smalley DM, Root KE, Cho H, Ross MM, Ley K
Thrombosis and haemostasis 2007 Jan;97(1):67-80
Thrombosis and haemostasis 2007 Jan;97(1):67-80
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- COLO 320 cells were subjected to SDS PAGE followed by western blot with 10281-1-AP(LGALS3BP antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The LGALS3BP antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human LGALS3BP. This antibody recognizes human antigen. The LGALS3BP antibody has been validated for the following applications: ELISA, WB, IP analysis.
